Inactive Instrument

Highlights Yield10 Bioscience Inc Nasdaq

Equities

US98585K1025

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

Yield10 Bioscience, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Apr. 01	CI
Yield10 Bioscience, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 01	CI
Yield10 Bioscience, Inc. Announces the Plant Biosafety Office of the Canadian Food Inspection Agency Clear Genome-edited E3902 Camelina for Planting in Canada	Mar. 26	CI
Top Midday Gainers	Mar. 21	MT
Yield10 Bioscience, Inc. Grants Global License to VISION Bioenergy Oilseeds, LLC for Herbicide Tolerant Camelina Cultivated for Production of Biofuel Feedstock	Feb. 14	CI
North American Morning Briefing : Stock Futures -2-	Feb. 09	DJ
Yield10 Bioscience, Inc. Provides an Update on Its Omega-3 Camelina Program	Feb. 07	CI
Yield10 Bioscience, Inc. Files Request for Regulatory Status Review with USDA-APHIS for Camelina Designed to Produce the EPA and DHA Components of Omega-3 Oil	Jan. 08	CI
Yield10 Bioscience, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
Yield10 Bioscience, Inc. and Biomar Group Aim to Grow Fish Oil on Land	23-10-31	CI
Yield10 Bioscience, Inc. Exercises Option to Finalize an Exclusive, Global Commercial License to Advanced Omega-3 Production Technology from Rothamsted Research	23-10-19	CI
Yield10 Bioscience Exercises Option to Finalize an Exclusive, Global Commercial License to Advanced Omega-3 Camelina Technology from Rothamsted Research	23-10-18	CI
Yield10 Bioscience, Inc. Provides Update on Recent Advancements in the Development of Elite Herbicide Tolerant Camelina	23-10-11	CI
Yield10 Bioscience, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14	CI
Yield10 Bioscience, Inc. Announces Positive Results in the First Field Test of Stacked Herbicide Tolerance Traits in Camelina	23-08-02	CI
Yield10 Bioscience Files Request for Regulatory Status Review Under Usda-Aphis?S Secure Rule Covering Elite Camelina Designed to Produce the EPA Component of Omega-3 Oil	23-07-26	CI
Yield10 Bioscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-10	CI
Yield10 Bioscience, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	23-03-14	CI
Yield10 Bioscience, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-14	CI
Earnings Flash (YTEN) YIELD10 BIOSCIENCE Posts Q4 Revenue $87,000, vs. Street Est of $0.13M	23-03-14	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Yield10 Bioscience Inc Nasdaq

Equities

US98585K1025

Highlights

Filters